Patty Eisenhaur
Contatto Relazioni con gli Investitori presso MOMENTA PHARMACEUTICALS, INC.
Profilo
Patty Eisenhaur is currently working as an Investor Relations Contact at Momenta Pharmaceuticals, Inc. and as a Senior Strategist at EVC Group, Inc. Previously, she worked as the Head-Investor Relations at Curia Global, Inc. from 2014 to 2018.
Posizioni attive di Patty Eisenhaur
| Società | Posizione | Inizio |
|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Contatto Relazioni con gli Investitori | - |
| EVC Group, Inc. | Corporate Officer/Principal | - |
Precedenti posizioni note di Patty Eisenhaur
| Società | Posizione | Fine |
|---|---|---|
| ALBANY MOLECULAR RESEARCH, INC. | Contatto Relazioni con gli Investitori | 01/06/2018 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Curia Global, Inc.
 Curia Global, Inc. Miscellaneous Commercial ServicesCommercial Services Curia Global, Inc. engages in drug research and development, and manufacturing. It offers drug delivery, drug development, analytical services, API development and manufacturing, and drug product solutions. The company was founded by Thomas E. D'Ambra on June 19, 1991 and is headquartered in Albany, NY. | Commercial Services |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
| EVC Group, Inc. |
- Borsa valori
- Insiders
- Patty Eisenhaur
